COVID-19 Investigational Medication Study

Study Now Open in NE & NY

People living with another who has tested positive for COVID-19 within the past 4 days may be able to join a research study for an investigational COVID-19 medication. In this placebo-controlled study, participants may receive a non-active placebo to see how it compares to the investigational drug.

Eligible participants…

  • Must be 18 or older
  • Must have household exposure to an individual who is symptomatic and tested positive for SARS-CoV-2 within the past 4 days
  • Must NOT be experiencing any symptom of COVID-19, e.g., cough; fever; shortness of breath; diarrhea; headache; sore throat; chills; loss of smell/taste
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240 (NY) or (712) 639-6200 (NE).

Submit your information

Expect Excellence icon - supporting research since 1999

Study Locations


  • Grand IslandMeridian Clinical Research, 2444 West Faidley Avenue, Grand Island, NE 68803

New York

  • Endwell: Meridian Clinical Research, 415 Hooper Road, Endwell, NY 13760

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.